ALLERGY & ASTHMA
January 2006 Some Selected Abstracts: |
|
1. |
Bush
A.How has research in the last five years changed my clinical practice?
Arch Dis Child. 2005 Aug;90(8):832-6. Department
of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney
Street, London SW3 6NP, UK. He
first instruction to examination candidates is to read and answer the
question actually set. Doing so in this case leads to the following
CONCLUSIONS: how research has changed my clinical practice includes the
act of doing research, as well as reading about the work of others.
Thus, this article refers to my own clinical practice (tertiary referral
paediatric respiratory medicine in a setting where we do not service an
accident and emergency department), rather than that of others. This
means excluding important conditions such as acute croup and
uncomplicated community acquired pneumonia. I should write about what
has changed my practice, not what other people think I ought to have
changed. So this will be a personal view, limited to research published
in a peer review format at the time of writing. I shall also assume that
change is an ongoing process, so I shall include change in progress,
provided it is supported by published literature. |
2. |
Cantani
A, Micera M Neonatal cow milk sensitization in 143 case-reports: role of
early exposure to cow's milk formula. Eur Rev Med Pharmacol Sci. 2005
Jul-Aug;9(4):227-30. Department
of Pediatrics, Allergy and Clinical Immunology Division, La Sapienza
University--Rome, Italy. OBJECTIVE:
Cow's milk (CM) allergy (CMA) is a disease of infancy, usually appearing
in the first months of life. Symptoms triggered by CM at first
introduction are not completely defined. The evaluation of infants for
possible CMA is one of the more common problems encountered by
pediatricians. Purpose of this study was to investigate the prevalence
of severe reaction to CM and clinical manifestation triggered by CM
administration in the nurseries. MATERIALS AND METHODS: The series
includes 143 prospectively studied CM-allergic babies. RESULTS: At the
first introduction of CM, at the age of 1-8 months (median 4 months) all
infants had immediate symptoms The babies were probably sensitized
during the first days of life. Particularly sensitizing appears to be
the exposure to CM formulas in the neonatal nursery. DISCUSSION: Little
doses of allergens are more sensitizing than larger ones. We provide
clear evidence of the immunological effects of oral antigen
administration during the neonatal period, and discuss the possible
critical allergen transmission to the nursing baby via breast milk (BM). |
3. |
Chinen
J, Shearer WT. Basic and clinical immunology. J Allergy Clin Immunol.
2005 Aug;116(2):411-8. Genetics
and Molecular Biology Branch, National Human Genome Research Institute,
National Institutes of Health, Bethesda, MD 20892, USA. The authors selected articles published in the literature from January 2004 through December 2004 that were relevant to the areas of basic and clinical immunology. Several articles explored the development of TH1 or TH2 response and the role of the monocyte-T cell interaction. Others were articles describing the action of drugs commonly used in asthma to inhibit cytokine responses and the anti-inflammatory role of nonimmune pulmonary cells present in the lung. Several reports show how dendritic cells are being developed as vehicles for DNA vaccines aimed at stimulating cellular responses, an advance of great importance for HIV researchers working on vaccines, who are concerned about the different ways HIV evades the immune response. Other publications described Toll-like receptors in diverse cells, including mast cells and CD4+ T cells, for the recognition of viruses and bacteria. In the area of clinical immunology, an updated classification for primary immunodeficiencies with more than 100 identified genes responsible for these diseases and the report on the second clinical trial of gene therapy for X-linked severe combined immunodeficiency syndrome were published. Significant advances included the clinical prognosis in common variable immunodeficiency for patients presenting with lung pathology, the safety of live vaccines in partial DiGeorge syndrome, the report of patients with complete DiGeorge syndrome with the presence of peripheral blood T cells, the clinical spectrum of patients with NF-kappaB essential modifier (NEMO) gene deficiency, the publication of a consensus algorithm for the management of hereditary angioedema, and the report of immune restoration syndrome in pediatric HIV infection. |
4. |
Ingram
P, Lavery I. Peripheral intravenous therapy: key risks and implications
for practice. Nurs Stand. 2005 Jul 27-Aug 2;19(46):55-64; quiz 66. Personnel,
environment and procedures related to peripheral intravenous (IV)
therapy are explained. Parenteral routes are suggested and, where
peripheral IV therapy is required, recommendations are made to minimize
risk of anaphylaxis and infection. |
5. |
Kimata
H. Brain-derived neurotrophic factor selectively enhances
allergen-specific IgE production. Neuropeptides. 2005 Aug;39(4):379-83 Department
of Allergy, Satou Hospital, 65-1, Yabuhigashimachi, Hirakata-City, Osaka
Prefecture 573-1124, Japan. We
studied the effect of brain-derived neurotrophic factor (BDNF) on in
vitro Japanese cedar pollen (JCP)-specific IgE production by mononuclear
cells from atopic keratoconjunctivitis patients with JCP allergy. BDNF
enhanced JCP-specific IgE production in a dose-dependent fashion in
cultures of mononuclear cells stimulated with JCP, and maximal
enhancement was achieved at 10 ng/ml. In contrast, BDNF had no effect on
JCP-specific IgA or IgG4 production. On the other hand, other
neurotrophins, NGF, NT-3, or NGF failed to enhance JCP-specific IgE
production. Moreover, anti-BDNF mAb specifically blocked BDNF-induced
enhancement of JCP-specific IgE production. Study for cytokine
production revealed that BDNF decreased production of Th1 cytokines, IFN-gamma
and IL-12, while it had no effect on production of TH2 cytokines, IL-4,
IL-10 and IL-13, in cultures of mononuclear cells stimulated with JCP.
These results indicate that BDNF relatively skews cytokine pattern
toward Th2 type. Collectively, BDNF may increase allergen-specific IgE
production, which may in turn aggravate allergic symptoms. |
6. |
Kwah YC, Leow YH.Not all pustules are infective in nature: acute generalised exanthematous pustulosis causing pustular eruptions in an elderly woman. Singapore Med J. 2005 Jul;46(7):349-51. National
Skin Centre, 1 Mandalay Road, Singapore 308205. raykyc@yahoo.com Acute
generalised exanthematous pustulosis (AGEP) is an adverse drug reaction
that can occur in any age group. It is commonly mistaken as pustular
psoriasis or cutaneous infection, resulting in unnecessary commencement
of medications such as methotrexate and antibiotics that can cause harm
to the patient or interact and adversely affect the efficacy of other
medications. Early diagnosis of AGEP avoids unnecessary investigations
and treatment, which not only can harm the patient but also escalate
health care, as the condition is self-limiting. This case report
illustrates AGEP secondary to Cefaclor occurring in a 72-year-old
Chinese woman. Although the literature has documented the occurrence of
AGEP with Cefaclor, the unique feature of this case is the occurrence of
AGEP following repeated uneventful courses of Cefaclor. This case
highlights that AGEP must never be forgotten in the work-up for pustular
eruptions in an elderly patient. |
7. |
Shek
LP, Bardina L, Castro R, Sampson HA, Beyer K Humoral and cellular
responses to cow milk proteins in patients with milk-induced IgE-mediated
and non-IgE-mediated disorders. Allergy. 2005
Jul;60(7):912-9. Division
of Pediatric Allergy and Immunology and The Jaffe Institute for Food
Allergy, The Mount Sinai School of Medicine, New York, NY 10029-6574,
USA.
|
8. |
Yen
ZS, Chen SC.Best evidence topic report. Nebulised furosemide in acute
adult asthma. Emerg Med J. 2005 Sep;22(9):654-5. Department
of Emergency Medicine, Manchester Royal Infirmary, Oxford Road,
Manchester M13 9WL, UK. A
short cut review was carried out to establish whether the addition of
nebulised furosemide to beta-agonist therapy improves outcomes in acute
asthma. Altogether 87 papers were found using the reported search, of
which two presented the best evidence to answer the clinical question. A
further relevant paper was found on scanning the references of these
papers. The author, date and country of origin, patient group studied,
study type, relevant outcome, results, and study weaknesses of the best
papers are tabulated. There is currently insufficient evidence to
support the routine addition of nebulised furosemide to standard beta
agonist therapy in acute asthma in adults. |
Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics: |
|
13122. Boyd R, Stuart P. Pressurised metered dose inhalers with spacers versus nebulisers for beta-agonist delivery in acute asthma in children in the emergency department. Emerg Med J. 2005 Sep;22(9):641-2. 13123. Bozkurt B, Karakaya G, Kalyoncu AF. Seasonal rhinitis, clinical characteristics and risk factors for asthma. Int Arch Allergy Immunol. 2005 Sep;138(1):73-9. 13124. Bustos P, Amigo H, Oyarzun M, Rona RJ. Is there a causal relation between obesity and asthma? Evidence from Chile. Int J Obes (Lond). 2005 Jul;29(7):804-9. 13125. Cotton D. Asthma and invasive pneumococcal disease. N Engl J Med. 2005 Aug 18;353(7):738-9; author reply 738-9. 13126. de Jong PA, Muller NL, Pare PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J. 2005 Jul;26(1):140-52. Review. 13127. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol. 2005 Aug;116(2):267-73. 13128. Gabrielli M, Candelli M, Cremonini F, Ojetti V, Santarelli L, Nista EC, Nucera E, Schiavino D, Patriarca G, Gasbarrini G, Pola P, Gasbarrini A. Idiopathic chronic urticaria and celiac disease. Dig Dis Sci. 2005 Sep;50(9):1702-4. 13129. Gangur V, Kelly C, Navuluri L. Sesame allergy: a growing food allergy of global proportions? Ann Allergy Asthma Immunol. 2005 Jul;95(1):4-11; quiz 11-3, 44. Review. 13130. Goetz DW, Whisman BA, Goetz AD. Cross-reactivity among edible nuts: double immunodiffusion, crossed immunoelectrophoresis, and human specific igE serologic surveys. Ann Allergy Asthma Immunol. 2005 Jul;95(1):45-52. 13131. Gompels MM, Lock RJ. C1 inhibitor deficiency: diagnosis. Clin Exp Dermatol. 2005 Jul;30(4):460-2. Review. 13132. Gupta A. T-cells and B-cells in bronchial asthma. Acta Ciene Indica-Chem 2003,29(3), 223-5. 13133. Helms PJ. Exercise induced asthma: real or imagined? Arch Dis Child. 2005 Sep;90(9):886-7. Review. 13134. Kamath AV, Pavord ID, Ruparelia PR, Chilvers ER. Is the neutrophil the key effector cell in severe asthma? Thorax. 2005 Jul;60(7):529-30. 13135. Kwah YC, Leow YH. Not all pustules are infective in nature: acute generalised exanthematous pustulosis causing pustular eruptions in an elderly woman. Singapore Med J. 2005 Jul;46(7):349-51. 13136. Lepper PM, Koenig W, Moller P, Perner S. A case of sudden cardiac death due to isolated eosinophilic coronary arteritis. Chest. 2005 Aug;128(2):1047-50. 13137. Mainali ES, Kikuchi T, Tew JG. Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood. Pediatr Res. 2005 Jul;58(1):125-31. 13138. Martelli A, Bouygue GR, Isoardi P, Marelli O, Sarratud T, Fiocchi A. Oral food challenges in children in Italy. Allergy. 2005 Jul;60(7):907-11. 13139. McKeown PF, Walsh SJ, Menown IB. Images in cardiology: An unusual case of right ventricular dilatation. Heart. 2005 Sep;91(9):1147. 13140. Oertel MF, Korinth MC, Reinges MH, Gilsbach JM. Pneumorrhachis of the entire spinal canal. J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1036. 13141. Oh SW, Lew W. Erythema multiforme induced by acetaminophen: a recurrence at distant sites following patch testing. Contact Dermatitis. 2005 Jul;53(1):56-7. 13142. Paquet P, Jacob E, Pierard GE. Cystic lesion of the parotid following drug-induced toxic epidermal necrolysis (Lyell's syndrome). J Oral Pathol Med. 2005 Jul;34(6):380-2. 13143. Saxena S, Joshi JM. Multiple pulmonary nodules. Indian J Chest Dis Allied Sci. 2005 Jul-Sep;47(3):193-5. 13144. Seear M, Wensley D, West N. How accurate is the diagnosis of exercise induced asthma among Vancouver schoolchildren? Arch Dis Child. 2005 Sep;90(9):898-902. 13145 Yasui K, Kobayashi N, Yamazaki T, Koike K, Fukushima K, Taniuchi S, Kobayashi Y. Neutrophilic inflammation in childhood bronchial asthma. Thorax. 2005 Aug;60(8):704-5.
|
|
Pathogenesis |
|
13146. Cantani A, Micera M. Neonatal cow milk sensitization in 143 case-reports: role of early exposure to cow's milk formula. Eur Rev Med Pharmacol Sci. 2005 Jul-Aug;9(4):227-30. 13147. Cavarape A, Quinkenstein E, Pizzolitto S, Soardo G, Sechi L. Henoch-Schonlein purpura in a patient with diabetic nephropathy and vascular complications. Nephrol Dial Transplant. 2005 Jul;20(7):1514-5. 13148. Cruz AA. The 'united airways' require an holistic approach to management. Allergy. 2005 Jul;60(7):871-4. 13149. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res. 2005 Jul;52(1):72-82. Review. 13150. Kalman S, Ibrahim Aydin H, Atay A. Henoch-Schonlein purpura in a child following varicella. J Trop Pediatr. 2005 Aug;51(4):240-1. 13151. Kimata H. Brain-derived neurotrophic factor selectively enhances allergen-specific IgE production. Neuropeptides. 2005 Aug;39(4):379-83. 13152. Lin S, Reibman J, Bowers JA, Hwang SA, Hoerning A, Gomez MI, Fitzgerald EF. Upper respiratory symptoms and other health effects among residents living near the World Trade Center site after September 11, 2001. Am J Epidemiol. 2005 Sep 15;162(6):499-507. 13153. McMillan JJ. Fungus sensitivity as a cause of Meniere's disease? Arch Otolaryngol Head Neck Surg. 2005 Sep;131(9):830. 13154. Mills EN, Breiteneder H. Food allergy and its relevance to industrial food proteins. Biotechnol Adv. 2005 Sep;23(6):409-14. Review. 13155. Rees J. ABC of asthma. Prevalence. BMJ. 2005 Aug 20;331(7514):443-5. Review. 13156. Shek LP, Bardina L, Castro R, Sampson HA, Beyer K. Humoral and cellular responses to cow milk proteins in patients with milk-induced IgE-mediated and non-IgE-mediated disorders. Allergy. 2005 Jul;60(7):912-9. 13157. Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. Am J Respir Crit Care Med. 2005 Jul 1;172(1):61-6. 13158. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A. The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005 Jul;49(1):65-76. Review. 13159. Vercelli D. Genetic regulation of IgE responses: Achilles and the tortoise. J Allergy Clin Immunol. 2005 Jul;116(1):60-4. Review. 13160. Yacoub MR, Lemiere C, Malo JL. Asthma caused by cyanoacrylate used in a leisure activity. J Allergy Clin Immunol. 2005 Aug;116(2):462. |
|
Vaccines: |
|
13161. Chinen J, Shearer WT. Basic and clinical immunology. J Allergy Clin Immunol. 2005 Aug;116(2):411-8. Review. 13162. Donnelly JJ, Wahren B, Liu MA. DNA vaccines: progress and challenges. J Immunol. 2005 Jul 15;175(2):633-9. Review. 13163. Kinet JP. A new strategy to counter allergy. N Engl J Med. 2005 Jul 21;353(3):310-2. 13164. Saxton JG. Do we truly understand vaccine reactions and vaccinosis? Homeopathy. 2005 Jul;94(3):200-1. Review. |
|
Therapy: |
|
13165. Aitkenhead AR. Injuries associated with anaesthesia. A global perspective. Br J Anaesth. 2005 Jul;95(1):95-109. 13166. Altman KW, Stephens RM, Lyttle CS, Weiss KB. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope. 2005 Jul;115(7):1145-53. 13167. Arshad SH. Primary prevention of asthma and allergy. J Allergy Clin Immunol. 2005 Jul;116(1):3-14; quiz 15. Review. 13168. Atherton D. Maintaining healthy skin in infancy using prevention of irritant napkin dermatitis as a model. Community Pract. 2005 Jul;78(7):255-7. Review. 13169. Bailie GR, Clark JA, Lane CE, Lane PL. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005 Jul;20(7):1443-9. 13170. Barnard A. Management of an acute asthma attack. Aust Fam Physician. 2005 Jul;34(7):531-4. Review. Erratum in: Aust Fam Physician. 2005 Aug;34(8):616. 13171. Bayraktar MR, Mehmet N, Durmaz R. Serum cytokine changes in Turkish children infected with Giardia lamblia with and without allergy: Effect of metronidazole treatment. Acta Trop. 2005 Aug;95(2):116-22. 13172. Bush A. How has research in the last five years changed my clinical practice? Arch Dis Child. 2005 Aug;90(8):832-6. Review. 13173. Cady RK, Dodick DW, Levine HL, Schreiber CP, Eross EJ, Setzen M, Blumenthal HJ, Lumry WR, Berman GD, Durham PL. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005 Jul;80(7):908-16. Review. 13174. Currie GP, Anderson WJ, Lee DK. Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy. J Allergy Clin Immunol. 2005 Jul;116(1):230. 13175. Currie GP, Devereux GS. Surgery for difficult persistent asthma. Thorax. 2005 Aug;60(8):706. 13176. Dewachter P, Mouton-Faivre C, Trechot P, Lleu JC, Mertes PM. Severe anaphylactic shock with methylene blue instillation. Anesth Analg. 2005 Jul;101(1):149-50. 13177. Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin. 2005 Jul;21(7):1075-84. Review. 13178. Hepner DL. From the laboratory to the bedside: searching for an understanding of anaphylaxis. Anesthesiology. 2005 Jul;103(1):1-2. 13179. Hon KL, Leung TF, Wong Y, So HK, Li AM, Fok TF. A survey of bathing and showering practices in children with atopic eczema. Clin Exp Dermatol. 2005 Jul;30(4):351-4. 13180. Hughes MA, Parisi M, Grossman S, Kleinberg L. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1423-6. 13181. Ingram P, Lavery I. Peripheral intravenous therapy: key risks and implications for practice. Nurs Stand. 2005 Jul 27-Aug 2;19(46):55-64; quiz 66. Review. 13182. Iqbal H, Evans A. Dapsone therapy for Henoch-Schonlein purpura: a case series. Arch Dis Child. 2005 Sep;90(9):985-6. 13183. Kankaanranta H, Moilanen E, Zhang X. Pharmacological regulation of human eosinophil apoptosis. Curr Drug Targets Inflamm Allergy. 2005 Aug;4(4):433-45. Review. 13184. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, Levy E. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005 Jul 25;165(14):1637-42. 13185. MacDonald A, Forsyth A. Nutritional deficiencies and the skin. Clin Exp Dermatol. 2005 Jul;30(4):388-90. 13186. Murch SH. Probiotics as mainstream allergy therapy? Arch Dis Child. 2005 Sep;90(9):881-2. 13187. Murphy E, Martin S, Patterson JV. Developing practice guidelines for the administration of intravenous immunoglobulin. J Infus Nurs. 2005 Jul-Aug;28(4):265-72. Review. 13188. Rees J. Methods of delivering drugs. BMJ. 2005 Sep 3;331(7515):504-6. Review. 13189. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax. 2005 Sep;60(9):740-6. 13190. Rogovik AL, Goldman RD. Treating infants' colic. Can Fam Physician. 2005 Sep;51:1209-11. Review. 13191. Sheikh A, Walker S. Anaphylaxis. BMJ. 2005 Aug 6;331(7512):330. Review. 13192. Yen ZS, Chen SC. Best evidence topic report. Nebulised furosemide in acute adult asthma. Emerg Med J. 2005 Sep;22(9):654-5. Review.
|
|
April 2006 Some Selected Abstracts: |
|
|
Aghayev E, Yen K, Sonnenschein M, Jackowski C, Thali M, Vock P, Dirnhofer R.Pneumomediastinum and soft tissue emphysema of the neck in postmortem CT and MRI; a new vital sign in hanging? Forensic Sci Int. 2005 Oct 29;153(2-3):181-8. Institute of Forensic Medicine, University of Bern, Buehlstrasse 20, 3012 Bern, Switzerland. emin.aghayev@irm.unibe.ch Spontaneous pneumomediastinum commonly occurs in healthy young men or parturient women in whom an increased intra-alveolar pressure (Valsalva maneuver, asthma, cough, emesis) leads to the rupture of the marginal pulmonary alveoli. The air ascends along the bronchi to the mediastinum and the subcutaneous space of the neck, causing cervico-fascial subcutaneous emphysema in 70-90% of cases. Ninety-five forensic cases, including five cases of hanging, were examined using postmortem multi-slice computed tomography (MSCT) and magnetic resonance imaging (MRI) prior to autopsy until December 2003. This paper describes the findings of pneumomediastinum and cervical emphysema in three of five cases of hanging. The mechanism of its formation is discussed based on these results and a review of the literature. In conclusion, when putrefaction gas can be excluded the findings of pneumomediastinum and cervical soft tissue emphysema serve as evidence of vitality of a hanged person. Postmortem cross-sectional imaging is considered a useful visualization tool for emphysema, with a great potential for examination and documentation. |
2. |
Arora R, Gal TJ, Hagan LL. An unusual case of laryngomalacia presenting as asthma refractory to therapy. Ann Allergy Asthma Immunol. 2005 Dec;95(6):607-11. Department
of Allergy/Immunology, Wilford Hall Medical Center, Lackland AFB, Texas
78236-5300, USA. rajiv.arora@us.army.mil BACKGROUND: Laryngomalacia is the most common cause of stridor in infants, but few reports exist of clinically relevant laryngomalacia in adults. OBJECTIVE: To present and discuss an unusual late presentation of laryngomalacia and its significance in the evaluation and management of asthma. METHODS: An 18-year-old woman presented to an academic medical center with symptoms of "wheezing" on inspiration and exertion, with relatively normal spirometric findings. She was clinically diagnosed as having asthma at the age of 13 years, but her symptoms were poorly controlled by maximal medical therapy. Further evaluation with rhinolaryngoscopy demonstrated laryngomalacia characterized by redundant soft tissue overlying the right arytenoid cartilage and aryepiglottic fold. RESULTS: The patient demonstrated positive bronchoprovocation, with a 33% decrease in forced expiratory volume in 1 second after the administration of histamine, 1 mg/mL. However, with the otolaryngology evaluation, it was determined that her laryngeal findings were clinically significant. She subsequently underwent operative laryngoscopy with carbon dioxide laser excision of the laryngeal abnormality, resulting in improvement in her symptoms and a marked decrease in her need for asthma medication. CONCLUSIONS: We report an unusual case of laryngomalacia presenting as asthma that was successfully treated with laser surgical excision. This case emphasizes the necessity of differentiating classic wheezing from stridor and upper airway obstruction. |
3. |
Chu KA, Wu YC, Lin MH, Wang HC. Acupuncture resulting in immediate bronchodilating response in asthma patients. J Chin Med Assoc. 2005 Dec;68(12):591-4. Division of
Chest Medicine, Department of Internal Medicine, Kaohsiung Veterans
General Hospital, 386, Ta-Chung 1st Road, Kaohsiung 813, Taiwan, ROC. kachu@vghks.gov.tw There are
some encouraging results in the English literature that show acupuncture
resulting in an immediate improvement in pulmonary function, but there
are also studies that have not demonstrated any benefit. We present 3
patients with persistent asthma who experienced immediate
bronchodilatation after acupuncture without the use of any short-acting
bronchodilator. After needle stimulation on selected acupoints, clinical
symptoms such as dyspnea and wheezing improved. Pulmonary function test
showed immediate improvement in forced expiratory
volume in 1 second (FEV1), more than 20% as compared with
baseline FEV1. Pulmonary function returned to baseline within 4 hours
after acupuncture in 2 patients. From our observations of these 3 asthma
patients, acupuncture may improve clinical dyspnea symptoms and
performance on pulmonary function tests. Further large-scale controlled
studies should be conducted to determine the effectiveness of
acupuncture in the treatment of asthma. |
4. |
Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005 Oct;33 (10 Suppl): S390-7. Division of
Maternal-Fetal Medicine, Medical University of South Carolina,
Charleston, SC, USA. OBJECTIVE: Historically, pneumonia during pregnancy has been associated with increased morbidity and mortality compared with nonpregnant women. The goal of this article is to review current literature describing pneumonia in pregnancy. This review will identify maternal risk factors, potential complications, and prenatal outcomes associated with pneumonia and describe the contemporary management of the varied causes of pneumonia in pregnancy. RESULTS: Coexisting maternal disease, including asthma and anemia, increase the risk of contracting pneumonia in pregnancy. Neonatal effects of pneumonia in pregnancy include low birth weight and increased risk of preterm birth, and serious maternal complications include respiratory failure. Community-acquired pneumonia is the most common form of pneumonia in pregnancy, with Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae accounting for most identified bacterial organisms. Beta-lactam and macrolide antibiotics are considered safe in pregnancy and are effective for most community-acquired pneumonia in pregnancy. Viral respiratory infections, including varicella, influenza, and severe acute respiratory syndrome, can be associated with maternal pneumonia. Current antiviral and respiratory therapies can reduce maternal morbidity and mortality from viral pneumonia. Influenza vaccination can reduce the prevalence of respiratory hospitalizations among pregnant women during influenza season. Pneumocystis pneumonia continues to carry significant maternal risk to an immunocompromised population. Prevention and treatment of Pneumocystis pneumonia with trimethoprim / sulfamethoxazole is effective in reducing this risk. CONCLUSIONS: Prompt diagnosis and treatment with contemporary antimicrobial therapy and intensive care unit management of respiratory compromise has reduced the maternal morbidity and mortality due to pneumonia in pregnancy. Prevention with vaccination in at-risk populations may reduce the prevalence and severity of pneumonia in pregnant women. |
5. |
Levin ME, Motala C, Lopata AL. Anaphylaxis in a milk-allergic child after ingestion of soy formula cross-contaminated with cow's milk protein. Pediatrics. 2005 Nov;116(5):1223-5. Allergy
Clinic, School of Child and Adolescent Health, Red Cross War Memorial
Children's Hospital, Cape Town, South Africa. mlevin@ich.uct.ac.za In this
report we describe a 9-month-old boy with severe persistent asthma and
documented cow's milk allergy (presented with eczema and severe systemic
reactions) who had an anaphylactic reaction to a soy formula
contaminated with cow's milk protein. Quantitative
enzyme-linked immunosorbent assay analysis revealed trace
quantities of beta-lactoglobulin in the offending soy formula as well as
the dry powder. The patient did not demonstrate clinical reactivity to
soy protein (negative challenge, tolerated pure soy formula well).
Cross-contamination of the offending soy formula was presumed to have
occurred during food manufacturing. This case demonstrates that trace
quantities of cow's milk protein can elicit severe systemic reactions in
highly milk-allergic individuals. This infant ingested the equivalent of
0.4 mL of cow's milk from the soy formula as documented by an
immunoassay for beta-lactoglobulin. This highlights the ease with which
cross-contamination can occur during food processing and reinforces the
need for better quality control. |
6. |
Meltzer DI. Complications of body piercing. Am Fam Physician. 2005 Nov 15;72(10):2029-34. Summary for patients in: Am Fam Physician. 2005 Nov 15;72(10):2035-6. State
University of New York at Stony Brook School of Medicine, Stony Brook,
New York, USA. donna.meltzer@stonybrook.edu The trend of
body piercing at sites other than the earlobe has grown in popularity in
the past decade. The tongue, lips, nose, eyebrows, nipples, navel, and
genitals may be pierced. Complications of body piercing include local
and systemic infections, poor cosmesis, and foreign body rejection.
Swelling and tooth fracture are common problems after tongue piercing.
Minor infections, allergic contact dermatitis, keloid formation, and
traumatic tearing may occur after piercing of the earlobe.
"High" ear piercing through the ear cartilage is associated
with more serious infections and disfigurement. Fluoroquinolone
antibiotics are advised for treatment of auricular perichondritis
because of their antipseudomonal activity. Many complications from
piercing are body-site-specific or related to the piercing technique
used. Navel, nipple, and genital piercings often have prolonged healing
times. Family physicians should be prepared to address complications of
body piercing and provide accurate information to patients. |
7. |
Reid G, Kirjaivanen P. Taking probiotics during pregnancy. Are they
useful therapy for mothers and newborns? Can Fam Physician. 2005 Nov;51:1477-9. Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute. QUESTION:
Recently, several of my pregnant patients have asked me about using
probiotics during pregnancy. Is there any evidence that these innocuous
bacteria work effectively? ANSWER: An increasing body of evidence
suggests that probiotics are effective for treating bacterial vaginosis
and allergic reactions. Most probiotics available in Canada, however,
are of dubious quality, and, for many claimed indications, there is no
proof of effectiveness yet. |
8. |
Restrepo RD, Pettignano R, DeMeuse P. Halothane, an effective
infrequently used drug, in the treatment of pediatric status asthmaticus:
a case report. J Asthma. 2005 Oct;42(8):649-51. Department of Cardiopulmonary Care Sciences, Georgia State University, and Division of Critical Care, Hughes Spalding Children's Hospital, Atlanta, Georgia, USA. restrepor@uthscsa.edu Asthma is
the most common chronic disease of childhood. Despite a better
understanding of the disease process and its management, status
asthmaticus continues to be a life-threatening event. The use of
volatile inhaled anesthetics is infrequently reported as adjunctive
therapy to conventional treatment of this condition. We report the use
of halothane in a mechanically ventilated pediatric patient with
life-threatening status asthmaticus who was admitted to the pediatric
intensive care unit (PICU) after failing to respond to standard medical
therapy and noninvasive positive pressure ventilation. A 12-year-old
African American male was seen in the emergency department and treated
with intravenous corticosteroids, beta-agonist therapy. He deteriorated
rapidly and required endotracheal intubation and mechanical ventilation.
Two hours later, the patient developed an acute, severe respiratory
acidosis (pH=6.97, PaCO2=171, PaO2=162, BE=1.7). Halothane was started
at 2% by using the Siemens Servo 900C anesthesia ventilator. Improvement
in both arterial blood gases and exhaled tidal volume were noted 30
minutes after initiation of the anesthetic gas. The patient remained on
halothane for a total of 36 hours. No adverse effects associated with
the use of halothane were noted. The patient was extubated to BiPAP
16/6, FiO2=0.30 at 68 hours and was discharged home 5 days later. |
9. |
Vegunta
RK, Raso M, Pollock J, Misra S, Wallace LJ, Torres A Jr, Pearl RH.
Biliary dyskinesia: the most
common indication for cholecystectomy in children. Surgery. 2005
Oct;138(4): 726-31;
discussion 731-3. University
of Illinois College of Medicine at Peoria, USA. vegunta@uic.edu BACKGROUND: The purpose of this study is to examine the current indications for cholecystectomy in children and to evaluate the results after such surgery. METHODS: Retrospective analysis of 107 consecutive cholecystectomies performed in children at the Children's Hospital of Illinois between October 1998 and September 2003. Hospital medical charts and outpatient clinic charts were reviewed. Patients' families were contacted by telephone to obtain longer-term follow-up. Results were analyzed with SPSS 12.0 for Windows (SPSS Inc, Chicago, Ill). RESULTS: Biliary dyskinesia (BD) was the indication for surgery for 62 (58%) of the 107 children who underwent cholecystectomy during the study period. Gallbladder calculus (GC) disease was the next most common indication with 29 (27%) children. The duration of symptoms was longer for BD. The most common presenting symptom in both groups was abdominal pain. Food intolerance was reported by 45% of patients with BD, significantly higher than patients with GC. Mean length of stay after cholecystectomy was 17 hours and 45 hours for BD and GC, respectively. Short-term follow-up showed relief or improvement of symptoms in 85% of children with BD and in 97% with GC. There were no deaths. Two (1.9%) children of the total of 107 developed complications; both had intra-abdominal abscesses. Most patients had complete or considerable long-term improvement in symptoms. CONCLUSIONS: Biliary dyskinesia was the most common indication for cholecystectomy in children in our study. More than half of the surgeries were performed on an outpatient basis. Morbidity was minimal and mortality was zero. We had satisfactory short- and long-term symptom resolution with long-term patient satisfaction reaching 95%. |
Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics: | |
13661. Armstrong PA, Pazona JF, Schaeffer AJ. Anaphylactoid reaction after retrograde pyelography despite preoperative
steroid preparation. Urology. 2005 Oct;66(4):880. 13662. Bangash SA, Bahna SL. Pediatric food allergy update. Curr Allergy
Asthma Rep. 2005 Nov;5(6):437-44. 13663. Becklake MR. Wheeze, asthma diagnosis and medication use in
developing countries. Thorax. 2005 Nov;60(11):885-7. 13664.
Bernstein JA. Chronic urticaria: an evolving story. Isr Med Assoc
J. 2005 Dec;7(12):774-7. 13665.
Berstad A, Arslan G, Lind R, Florvaag E. Food hypersensitivity-immunologic
(peripheral) or cognitive (central) sensitisation?
Psychoneuroendocrinology. 2005 Nov;30(10):983-9. 13666.
Buchvald F, Hermansen MN, Nielsen KG, Bisgaard H. Exhaled nitric
oxide predicts exercise-induced bronchoconstriction in asthmatic school
children. Chest. 2005 Oct;128(4):1964-7. 13667.
Dauer EH, Freese DK, El-Youssef M, Thompson DM. Clinical
characteristics of eosinophilic esophagitis in children. Ann Otol Rhinol
Laryngol. 2005 Nov;114(11):827-33. 13668.
David GL, Koh WP, Lee HP, Yu MC, London SJ. Childhood exposure to
environmental tobacco smoke and chronic respiratory symptoms in
non-smoking adults: the Singapore Chinese Health Study. Thorax. 2005
Dec;60(12):1052-8. 13669.
Ferrario F, Rastaldi MP. Henoch-Schonlein nephritis. J Nephrol.
2005 Nov-Dec;18(6):637-41. 13670.
Fruhauf J, Weinke R, Pilger U, Kerl H, Mullegger RR. Soft tissue
cervicofacial emphysema after dental treatment: report of 2 cases with
emphasis on the differential diagnosis of angioedema. Arch Dermatol.
2005 Nov;141(11):1437-40. 13671.
Garcia-Careaga M Jr, Kerner JA Jr. Gastrointestinal
manifestations of food allergies in pediatric patients. Nutr Clin Pract.
2005 Oct;20(5):526-35. Review. 13672.
Gomez Real F, Svanes C, Bjornsson EH, Franklin K, Gislason D,
Gislason T, Gulsvik A, Janson C, Jogi R, Kiserud T, Norback D, Nystrom
L, Toren K, Wentzel-Larsen T, Omenaas E. Hormone replacement therapy,
body mass index and asthma in perimenopausal women: a cross sectional
survey. Thorax. 2006 Jan;61(1):34-40.
13673.
Hendeles L, Marshik PL, Ahrens R, Kifle Y, Shuster J. Response to
nonprescription epinephrine inhaler during nocturnal asthma. Ann Allergy
Asthma Immunol. 2005 Dec;95(6):530-4. 13674.
Jani M, Ogston S, Mukhopadhyay S. Annual increase in body mass
index in children with asthma on higher doses of inhaled steroids. J
Pediatr. 2005 Oct;147(4):549-51. 13675.
Jindal SK, Gupta D, Aggarwal AN, Agarwal R; World Health
Organization; Government of India. Guidelines for management of asthma
at primary and secondary levels of health care in India (2005). Indian J
Chest Dis Allied Sci. 2005 Oct-Dec;47(4):309-43. Review. 13676.
Karatzios C, Bratu I, Flageole H, McDonald J. Chest pain and
pulmonary lesion in a child with asthma. Pediatr Infect Dis J. 2005
Nov;24(11):1026, 1031. 13677.
Kawai M, Nakashima M, Takaori S, Nakamura Y, Akamatsu K,
Nakashima M, Miyamoto T. Pharmacodynamic equivalence study of CFC-free
and CFC-containing procaterol hydrochloride metered-dose inhalers.
Methods Find Exp Clin Pharmacol. 2005 Oct;27(8):555-8.
13678.
Khan J. Eye know it's red. Lancet. 2005 Oct 29-Nov
4;366(9496):1583. 13679.
Kim CJ, Chung HY, Kim SY, Kim YO, Ryu SY, Kim JC, Chung JH. Acute
appendicitis in Henoch-Schonlein purpura: a case report. J Korean Med
Sci. 2005 Oct;20(5):899-900. 13680.
Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A,
Corcoran T, Gracely E, Funt N, Thompson A. Helium/oxygen-driven
albuterol nebulization in the treatment of children with moderate to
severe asthma exacerbations: a randomized, controlled trial. Pediatrics.
2005 Nov;116(5):1127-33. 13681.
Kristjansson S, Bjarnarson SP, Wennergren G, Palsdottir AH,
Arnadottir T, Haraldsson A, Jonsdottir I. Respirtory syncytial virus and
other respiratory viruses during the first 3 months of life promote a
local TH2-like response. J Allergy Clin Immunol. 2005 Oct;116(4):805-11.
13682.
Kroigaard M, Garvey LH, Menne T, Husum B. Allergic reactions in
anaesthesia: are suspected causes confirmed on subsequent testing? Br J
Anaesth. 2005 Oct;95(4):468-71. 13683.
Lang DM. Blocking
aspirin-induced bronchospasm. Ann Allergy Asthma Immunol. 2005
Oct;95(4):307-8. Review. 13684.
Mandell D, Curtis R, Gold M, Hardie S.
Anaphylaxis: how do you live with it? Health Soc Work. 2005
Nov;30(4):325-35. 13685.
McClelland VM, Brookfield DS.
Palpation reveals the diagnosis. Arch Dis Child. 2005
Dec;90(12):1278. 13686.
McIntyre CL, Sheetz AH, Carroll CR, Young MC. Administration of
epinephrine for life-threatening allergic reactions in school settings.
Pediatrics. 2005 Nov;116(5):1134-40. 13687.
Moss JR, Zanation AM, Shores CG. ACE inhibitor associated
recurrent intermittent parotid gland swelling. Otolaryngol Head Neck
Surg. 2005 Dec;133(6):992-4. 13688.
Nadarajah K, Green GR, Naglak M.
Clinical outcomes of penicillin skin testing.Ann Allergy Asthma
Immunol. 2005 Dec;95(6):541-5. 13689.
Neri I, Savoia F, Guareschi E, Medri M, Patrizi A.
Purpura after application of EMLA cream in two children. Pediatr
Dermatol. 2005 Nov-Dec;22(6):566-8.
13690.
Newcomb AE, Clarke CP. Spontaneous pneumomediastinum: a benign
curiosity or a significant problem? Chest. 2005 Nov;128(5):3298-302. 13691.
Nicol AA. Understanding peanut allergy: an overview of medical
and lifestyle concerns. Adv Nurse Pract. 2005 Oct;13(10):63-8. Review. 13692.
Opstelten W, van Essen GA, Moons KG, van Wijck AJ, Schellevis FG,
Kalkman CJ, Verheij TJ. Do
herpes zoster patients receive antivirals? A Dutch National Survey in
General Practice. Fam Pract. 2005 Oct;22(5):523-8.
13693.
Paajanen L, Korpela R, Tuure T, Honkanen J, Jarvela I, Ilonen J,
Knip M,Vaarala O, Kokkonen J.
Cow milk is not responsible for most gastrointestinal immune-like
syndromes--evidence from a population-based study. Am J Clin Nutr. 2005
Dec;82(6):1327-35. 13694.
Saarinen KM, Pelkonen AS, Makela MJ, Savilahti E. Clinical course
and prognosis of cow's milk allergy are dependent on milk-specific IgE
status. J Allergy Clin Immunol. 2005 Oct;116(4):869-75.
13695.
Schreck DM, Babin S. Comparison
of racemic albuterol and levalbuterol in the treatment of acute asthma
in the ED. Am J Emerg Med. 2005 Nov;23(7):842-7. 13696.
Sevar R. Audit of outcome in 455 consecutive patients treated
with homeopathic medicines. Homeopathy. 2005 Oct;94(4):215-21.
13697.
Soylu A, Kavukcu S, Erdur B, Demir K, Turkmen MA. Multisystemic
leukocytoclastic vasculitis affecting the central nervous system.
Pediatr Neurol. 2005 Oct;33(4):289-91. 13698.
Stover DE, Mangino D. Macrolides: a treatment alternative for
bronchiolitis obliterans organizing pneumonia? Chest. 2005
Nov;128(5):3611-7. 13699.
Wickens K, Barry D, Friezema A, Rhodius R, Bone N, Purdie G,
Crane J. Fast foods - are
they a risk factor for asthma? Allergy. 2005 Dec;60(12):1537-41. 13700.
Zacharisen M, Schoenwetter W. Fatal hypersensitivity pneumonitis.
Ann Allergy Asthma Immunol. 2005 Nov;95(5):484-7. 13701.
Zanconato S, Meneghelli G, Braga R, Zacchello F, Baraldi E.
Office spirometry in primary care pediatrics: a pilot study. Pediatrics.
2005 Dec;116(6):e792-7. Pathogenesis: 13702.
Allmers H. Frequent acetaminophen use and allergic diseases: is
the association clear? J Allergy Clin Immunol. 2005 Oct;116(4):859-62.
Review. 13703.
Bjorksten B. Evidence of probiotics in prevention of allergy and
asthma. Curr Drug Targets Inflamm Allergy. 2005 Oct;4(5):599-604.
Review. 13704.
Britton J. Passive smoking and asthma exacerbation. Thorax. 2005
Oct;60(10):794-5. 13705.
Corkins MR. Are diet and constipation related in children? Nutr
Clin Pract. 2005 Oct;20(5):536-9. Review. 13706.
Davoren M, Peake J. Cashew nut allergy is associated with a high
risk of anaphylaxis.Arch Dis Child. 2005 Oct;90(10):1084-5. 13707.
Demiraran Y, Kocaman B, Akman RY. A comparison of the
postoperative analgesic efficacy of single-dose epidural tramadol versus
morphine in children. Br J Anaesth. 2005 Oct;95(4):510-3.
13708.
Eskinazi D. Vaccinations:
for or against. Homeopathy. 2005 Oct;94(4):252-3.
13709.
Haroon M. Should children with Henoch-Schonlein purpura and
abdominal pain be treated with steroids? Arch Dis Child. 2005
Nov;90(11):1196-8. Review. 13710.
Holgate ST. Exacerbations: the asthma paradox. Am J Respir Crit
Care Med. 2005 Oct 15;172(8):941-3. Review.
13711.
Jolles S, Sewell WA, Misbah SA.
Clinical uses of intravenous immunoglobulin. Clin Exp Immunol.
2005 Oct;142(1):1-11. Review. Jun ZJ, Lei Y, Shimizu Y, Dobashi K, Mori
M. Helicobacter pylori seroprevalence in patients with mild asthma.
Tohoku J Exp Med. 2005 Dec;207(4):287-91. 13712.
King N, Helm R, Stanley JS, Vieths S, Luttkopf D, Hatahet L,
Sampson H, Pons L, Burks W, Bannon GA. Allergenic characteristics of a
modified peanut allergen. Mol Nutr Food Res. 2005 Oct;49(10):963-71. 13713.
Latha GS, Lakshmi VV, Rani HS, Anuradha B, Murthy KJR. Specific
IgG and its subclass antibodies after immunotherapy with gynandropsis
gynandra . Lung
India. 2005 Jul-Sept; 22(3): 77-80 13714.
Miller MM, Miller MM. Beta-blockers
and anaphylaxis: are the risks overstated? J Allergy Clin Immunol. 2005
Oct;116(4):931-3; author reply 933-6. 13715.
Richardson L. Re: "please read the following paper and write
this way!". Am J Epidemiol. 2005 Oct 1;162(7):706-7.
13716.
Romero-Frais E, Vazquez MI, Sandez E, Blanco-Aparicio M, Otero I,
Verea H. Prescription of
oral corticosteroids in near-fatal asthma patients: relationship with
panic-fear, anxiety and depression. Scand J Psychol. 2005
Oct;46(5):459-65. 13717.
Su SS, Yu KH, Woung PS. Comment: esomeprazole-induced central
fever with severe myalgia. Ann Pharmacother. 2005 Oct;39(10):1764;
author reply 1765. 13718.
van Rijt LS, van Kessel CH, Boogaard I, Lambrecht BN. Respiratory
viral infections and asthma pathogenesis: a critical role for dendritic
cells? J Clin Virol. 2005 Nov;34(3):161-9.
Review. 13719.
Ward MD, Selgrade MK. Benefits and risks in malaria control.
Science. 2005 Oct 7;310(5745):49-51; author reply 49-51.
13720.
Zanoni LZ, Palhares DB, Consolo LC. Myocardial ischemia induced
by nebulized fenoterol for severe childhood asthma. Indian Pediatr. 2005
Oct;42(10):1013-8. 13721.
Zinderman CE, Wise R, Landow L. Fluid solutions in dengue shock
syndrome. N Engl J Med. 2005 Dec 8;353(23):2510-1; author reply 2510-1.
Therapy: 13722.
Ahrens RC. The role of the MDI and DPI in pediatric patients:
"Children are not just miniature adults". Respir Care. 2005
Oct;50(10):1323-8; discussion 1328-30. Review. 13622.
Ali R, Ali S, Saeed SA, Khan A, Mustafa M, Aleem S. Latest
approaches to the diagnosis and management of food allergies in
children. J Pak Med Assoc. 2005 Oct;55(10):458-62. Review. 13624.
Arroliga A, Griswold S. "Frequent fliers" do not
receive a free trip in the emergency department. Chest. 2005
Dec;128(6):4051-2.
13625.
Boogaard R, Huijsmans SH, Pijnenburg MW, Tiddens HA, de Jongste
JC, Merkus PJ. Tracheomalacia and bronchomalacia in children: incidence
and patient characteristics. Chest. 2005 Nov;128(5):3391-7. 13626.
Choo-Kang LR. Becoming a complete "asthmologist".
Chest. 2005 Nov;128(5):3093-6.
13627.
Currie GP, Lee DK, Srivastava P. Long-acting bronchodilator or
leukotriene modifier as add-on therapy to inhaled corticosteroids in
persistent asthma? Chest. 2005 Oct;128(4):2954-62. Review. 13628.
Field T. Massage therapy for skin conditions in young children.
Dermatol Clin. 2005 Oct;23(4):717-21. Review. 13629.
Flores G, Abreu M, Tomany-Korman S, Meurer J. Keeping children
with asthma out of hospitals: parents' and physicians'perspectives on
how pediatric asthma hospitalizations can be prevented. Pediatrics. 2005
Oct;116(4):957-65. 13630.
Hanania NA, Belfort MA.
Acute asthma in pregnancy.Crit Care Med. 2005 Oct;33(10 Suppl):S319-24.
Review. 13631.
Martinez FD. Safety of long-acting beta-agonists--an urgent need
to clear the air. N Engl J Med. 2005 Dec 22;353(25):2637-9.
13632.
Nardi AE. Where are the guidelines for the treatment of asthma
with panic spectrum symptoms? Am J Respir Crit Care Med. 2005 Oct
15;172(8):1055-6; author reply 1056. 13633.
Nott MR. Helium-oxygen for asthma. Anaesthesia. 2005
Oct;60(10):1044-5.
13634.
Trumpelmann P, Jordan G, Townsend M. Hydrocortisone preparations
and latex. Anaesthesia. 2005 Dec;60(12):1246; discussion 1246-7.
13635.
Yeh SH, Chang FR, Wu YC, Yang YL, Zhuo SK, Hwang TL. An
anti-inflammatory ent-kaurane from the stems of Annona squamosa that
inhibits various human neutrophil functions. Planta Med. 2005
Oct;71(10):904-9.
|
|
July 2006 Some selected abstracts: |
|
1. |
Braganza SC, Acworth JP, Mckinnon DR. Peake JE, Brown AF, Paediatric emergency department anaphylaxis : different patterns from adults. Arch Dis. Child. 2006Feb; 91(2):159-63 Department of Emergency Medicine, Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia. BACKGROUND AND AIMS: Data on acute paediatric anaphylaxis presentations to the emergency department (ED) are limited. All allergic presentations to one Australian paediatric ED were studied to determine epidemiological, clinical, and outcome data. METHODS: Retrospective, case based study of patients under 16 years attending one metropolitan, paediatric teaching hospital ED in Australia over three years. The medical records of patients presenting with generalised allergic reactions and anaphylaxis satisfying relevant ICD-9-CM diagnostic codes were studied. The incidence, age, sex ratio, co-morbidities, likely aetiology, clinical features, management, and disposal were determined. RESULTS: A total of 526 children with generalised allergic reactions, and 57 with anaphylaxis were included in the study. This represented incidences of 9.3:1000 ED presentations for generalised allergic reactions and 1:1000 for anaphylaxis. There were no fatalities. In anaphylaxis cases, a cause was recognised in 68.4%. Cutaneous features were present in 82.5%. A past history of asthma was reported in 36.8%. Adrenaline was used in 39.3% of severe anaphylaxis cases. The ED alone definitively cared for 97.8% of all patients. Follow up was inadequate in cases of anaphylaxis. CONCLUSIONS: This is the first reported incidence figure for paediatric anaphylaxis ED presentations in Australia, and is less than that reported in adults in the same local population. However, the incidence of generalised allergic reactions of 9.3:1000 was greater than in the adults. Virtually all paediatric allergic cases may be managed in the ED alone, provided that the importance of specialist follow up, particularly for severe anaphylaxis, is recognised.
|
2 |
Carroll CL, Schramm CM. Noninvasive positive pressure ventilation for the treatment of status asthmaticus in children. Ann Allergy Asthma Immunol. 2006 Mar;96(3):454-9. Department of Pediatrics, Connecticut Children�s Medical Center, Hartford, Connecticut 06106, USA. ccarrol@ccmckids.org
BACKGROUND: Noninvasive positive pressure ventilation (NPPV) has been
used safely and effectively to improve gas exchange and to treat
respiratory failure in a variety of disease states. Although this
technique has some benefits in the treatment of status asthmaticus in
adults, the use of NPPV in pediatric patients with asthma has not been
described. OBJECTIVE: To describe the use of NPPV in the treatment of
pediatric status asthmaticus. METHODS: Retrospective review of children
admitted to the inten sive care unit with asthma who received NPPV as
part of their treatment between Octo ber 2002 and April 2004. Before and
after initiation of NPPV, data were collected regarding degree of
respiratory dysfunction. RESULTS: Of seventy-nine children admitted to
the intensive care unit during the study period for treatment of status
asthmaticus, 5 children (mean +/- SD age, 9.6 +/- 4.2 years) were
treated with NPPV. Four of the 5 children were morbidly obese, with a
mean +/- SD body mass index of 32 +/- 5. There was a statistically
significant improvement in respiratory rate (43 +/- 20 vs 31 +/- 12/min,
P = 03) and Modified Pulmonary Index Score (13.4 +/- 1.8 vs 11.4 +/-
1.5, P = .03) after initiation of NPPV. The mean +/- SD duration of
therapy was 33.2 +/- 23.9 hours, and children tolerated this therapy
well, requiring little or no anxiolytics. CONCLUSIONS: NPPV was well
tolerated in this series of children with status asthmaticus and can
improve subjective and objective measures of respiratory dysfunction.
NPPV may be a useful adjunct in the treatment of status asthmaticus in
children. |
3. |
Rowe BH, Camargo CA Jr; Multicenter Airway Research Collaboration (MARC) Inves tigators. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol. 2006 Jan;117(1):53-8. Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2B7. brian.rowe@ualberta.ca
BACKGROUND: Systematic reviews of approximately 13
randomized trials support treatment with intravenous magnesium sulfate
(MgSO(4)) in patients with severe acute asthma; however, little is known
about its actual clinical use. OBJECTIVE: We sought to examine the use
of intravenous MgSO(4) in the emergency department (ED) and physician
attitudes toward its use. METHODS: Data for MgSO(4) use were obtained
from observational cohort studies of ED patients with acute asthma.
Investigators were asked about MgSO(4) through a brief Internet-based
survey. The main outcomes were the percentage of sites reporting MgSO(4)
use and patient factors that potentially modified the use of this agent.
RESULTS: Among 9745 ED patients with acute asthma, 240 (2.5%) received
MgSO(4). Increasing age, previous intubation, higher initial respiratory
rate, lower initial PEF, higher number of beta-agonists in the ED, and
use of systemic corticosteroids were associated with MgSO(4) use (P <
.01). Overall, 103 (87%) of 119 potential sites completed the survey.
Most (92%) respondents stated their EDs had MgSO(4) available, and 64%
had recently used it. More respondents listed severity (96%) and failure
to respond to initial beta-agonists (87%) as factors prompting their use
of MgSO(4). Other factors, such as age, sex, and duration of
exacerbation, less commonly influenced MgSO(4) use. CONCLUSION: Most ED
physicians accept the efficacy of MgSO(4) in acute asthma. Despite this
belief and the ready availability of MgSO(4), its ED use remains
uncommon (2.5% of cases). In both practice and theory, emergency
physicians appear to appropriately restrict its use to patients with
severe acute asthma. |
4. |
Seddon P, Bara A, Ducharme FM, Lasserson TJ. Oral xanthines as maintenance treatment for asthma in children. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD00288 Royal Alexandra Hospital for Sick Children, Dyke Road, Brighton, Sussex, UK, BN1 3JN.freya.seddon@tesco.net BACKGROUND : Xanthines have been used in the treatment of asthma as a bronchodilator, though they may also have anti-inflammatory effects. The current role of xanthines in the long-term treatment of childhood asthma needs to be reassessed.
OBJECTIVES : To determine the efficacy of xanthines
(e.g. theophylline) in the maintenance treatment of paediatric asthma.
SEARCH STRATEGY: A search of the Cochrane Airways Group Specialised
Register was undertaken with predefined search terms. Searches are
current to May 2005. SELECTION CRITERIA : Randomised controlled
trials,lasting at least four weeks comparing a xanthine with placebo,
regular short-acting beta-agonist (SABA), inhaled corticosteroids (ICS),
cromoglycate (SCG), ketotifen (KET) or leukotriene antagonist, in
children with diagnosed with chronic asthma between 18 months and 18
years old. DATA COLLECTION AND ANALYSIS : Two reviewerd independently
selected each study for inclusion in the review and extracted data.
Primary outcome was percentage of symptom-free days. MAIN RESULTS:
Thirty- four studies (2734 participants) of adequate quality were
included. Xanthine versus placebo (17 studies): The proportion of
symptom free days was larger with xanthine compared with placebo (7.97%
[95% CI 3.41, 12.53]). Rescue medication usage was lower with xanthine,
with no significant difference in symptom scores or hospitalisations.
FEV1 , and PEF were better with xanthine. Xanthine was associated with
non - specific side-effects.Data from behavioural scores were
inconclusive. Xanthine versus ICS (four studies) :Exacerbations were
less frequent with ICS, but no significant difference on lung function
was observed. Individual studies reported significant improvements in
symptom measures in favour of steroids, and one study reported a
difference in growth rate in favour of xanthine. No difference was
observed for study withdrawal or tremor. Xanthine was associated with
more frequent headache and nausea. Xanthine versus regular SABA (10
studies): No significant difference in symptoms, rescue medication
usage and spirometry. Individual studies reported improvement in PEF
with beta-agonist. Beta-agonist treatment led to fewer hospitalisations
and headaches. Xanthine was associated with less tremor. Xanthine versus
SCG (six studies ): No significant difference in symptoms, exacerbations
and rescue medication. Sodium cromoglycate was associated with fewer
gastro-intestinal side-effected than xanthine. Xanthine versus KET (one
study): No statistical tests of significance between xanthine and
ketotifen were reported. Xanthine + ICS versus placebo + same dose ICS}
(three studies) : Results were conflicting due to
clinical/methodological differences, and could not be aggregated.
AUTHORS' CONCLUSIONS : Xanthines as first-line preventer alleviate
symptoms and reduce requirement for rescue medication in children with
mild to moderate asthma. When compared with ICS they were less effective
in preventing exacerbations.Xanthines had similar efficacy as single
preventative agent compared with regular SABA and SCG. Evidence on AEs
(adverse effects) was equivocal: there was evidence for increased AEs
overall, but no evidence that any specific AE (including effects on
behaviour and attention) occurred more frequently than with placebo.
There is insufficient evidence from available studies to make firm
conclusions about the effectiveness of xanthines as add-on preventative
treatment to ICS, and there are no published paediatric studies
comparing xanthines with alternatives in this role. Our data suggest
that xanthines are only suitable as first-line preventative asthma
therapy in children when ICS are not available. They may have a role as
add-on therapy in more severe asthma not controlled by ICS, but further
studies are needed to examine this, and to define the risk-benefit ratio
compared with other agents. |
5. |
Wigmore T, Stachowski E. A review of the use of heliox in the critically ill. Crit Care Resusc.2006 Mar;8(1):64-72. Intensive Care Unit, Westmead Hospital, Westmead, New South Wales. Heliox, a mix of oxygen and helium, has a number of potential medical applications resulting from its relatively lower density. This paper reviews the physics underlying its utility and considers the evidence for its use. While there are studies that support its role, particularly in patients with exacerbations of asthma and chronic obstructive pulmonary disease (COPD), the data are inconclusive. |
Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics: | |
14246. Al-Trabolsi HA, Alshehri M, Al-Shomrani A, Shabanah M, Al-Barki AA."Primary" pulmonary Langerhans cell histiocytosis in a two-year-old child: case report and literature review. J Pediatr Hematol Oncol. 2006 Feb;28(2):79-81. Review. 14247. Amado MC, Portnoy JM. Recent advances in asthma management. Mo Med. 2006 Jan-Feb;103(1):60-4. Review. 14248. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence- based clinical practice guidelines.Chest. 2006 Jan;129(1 Suppl):116S-121S. Review. 14249. Brightling CE. Sputum induction in asthma: a research technique or a clinical tool? Chest.2006 Mar;129(3):503-4. 14250. Chhabra SK. Premenstrual asthma. Indian J Chest Disall Sci. 2005; 47(2):109-16. 14251. Dinakar C, Craff M, Laskowski D.Infants and toddlers without asthma with eczema have elevated exhaled nitric oxide levels.J Allergy Clin Immunol. 2006 Jan;117(1):212-3. 14252. Doherty S.Evidence-based implementation of evidence-based guidelines.Int J Health Care Qual Assur Inc Leadersh Health Serv. 2006;19(1):32-41. 14253. Fitzgerald DA, Kozlowska K.Habit cough: assessment and management.Paediatr Respir Rev. 2006 Mar;7(1):21-5. Review. 14254. Flaherman V, Rutherford GW.A meta-analysis of the effect of high weight on asthma.Arch Dis Child. 2006 Apr;91(4):334-9. Review. 14255. Fuhlbrigge AL, Bae SJ, Weiss ST, Kuntz KM, Paltiel AD. Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density.J Allergy Clin Immunol. 2006 Feb;117(2):359-66.
14256. Gau JT, Carlsen W, Tomc M, Jenkinson
S, Shen R, Clay S. An elderly woman with
14257. Gruchalla RS, Pirmohamed M.Clinical
practice. Antibiotic allergy.N Engl J Med. 2006 14258. Hahn DL. Does most asthma really begin during the preschool years? Am J Respir Crit Care Med. 2006 Mar 1;173(5):575-6; Halterman JS, Fagnano M, Conn KM, Szilagyi PG. Do parents of urban children with persistent asthma ban smoking in their homes and cars? Ambul Pediatr. 2006 Mar-Apr;6(2):115-9. 14259. Hambrook DW, Fink JN. Airbag asthma: a case report and review of the literature. Ann Allergy Asthma Immunol. 2006 Feb;96(2):369-72. Review.
14260. Hong SH, Sanders BH, West D.
Inappropriate use of inhaled short acting beta-agonists 14261. Kaur C, Bansal SK, Chhabra SK. Study on serum and urinary cortisollevels of asthmatic patients after treatment with high dose inhaledbeclomethasone dipropionate or budesonide. Indian J Chest Dis all Sci. 2005; 47(2):89-95. 14262. Kwon HL, Belanger K, Holford TR, Bracken MB.Effect of fetal sex on airway lability in pregnant women with asthma. Am J Epidemiol. 2006 Feb 1;163(3):217-21. 14263. Nitta A, Suzumura H, Tsuboi Y, Yoshihara S, Arisaka O. Cow's milk allergy with severe atopic dermatitis in a 605-g extremely low birth weight infant. J Pediatr. 2006 Feb;148(2):282. 14264. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor D Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW. Second sympo sium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.J Allergy Clin Immunol. 2006 Feb;117(2):391-7. 14265. Schatz M, Dombrowski MP, Wise R, Momirova V, Landon M, Mabie W, Newman RB, Rouse DJ, Lindheimer M, Miodovnik M, Caritis SN, Leveno KJ, Meis P, Wapner RJ, Paul RH, O'Sullivan MJ, Varner MW, Thurnau GR, Conway DL; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network; National Heart, Lung, and Blood Institute. Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol. 2006 Jan;194(1):120-6. 14266. Simons FE. Anaphylaxis, killer allergy: long-term management in the community.J Allergy Clin Immunol. 2006 Feb;117(2):367-77. Review.
14267. Svedman C, Tillman C, Gustavsson CG,
Moller H, Frennby B, Bruze M. Contact allergy to gold in patients with
gold-plated intracoronary stents. Contact Dermatitis. 2006 14268. Ulger Z, Demir E, Tanac R, Goksen D, Gulen F, Darcan S, Can D, Coker M. The effect of childhood obesity on respiratory function tests and airway hyperresponsiveness. Turk J Pediatr. 2006 Jan-Mar;48(1):43-50. Therapy: 14269. Aaronson DW. The "black box" warning and allergy drugs. J Allergy Clin Immunol. 2006 Jan;117(1):40-4. 14270. Ait-Khaled N, Enarson DA. Management of asthma: the essentials of good clinical prac tice. Int J Tuberc Lung Dis. 2006 Feb;10(2):133-7. Review. 14271. Alonso A, Jick SS, Hernan MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology. 2006 Feb 28;66(4):572-5. 14272. Amon A, Pahl A, Szelenyi I. Can corticosteroids be beaten in future asthma therapy? Pharmazie. 2006 Feb;61(2):122-4. Review. 14273. Barnes PJ. Corticosteroids: the drugs to beat. Eur J Pharmacol. 2006 Mar 8;533(1-3):2- 14. Review. 14274. Basaran S, Guler-Uysal F, Ergen N, Seydaoglu G, Bingol-Karakoc G, Ufuk Altintas D. Effects of physical exercise on quality of life, exercise capacity and pulmonary function in children with asthma. J Rehabil Med. 2006 Mar;38(2):130-5. 14275. Broadley KJ. Beta-adrenoceptor responses of the airways: for better or worse? Eur J Pharmacol. 2006 Mar 8;533(1-3):15-27. Review. 14276. Camargo CA Jr. Prevention of emergency department visits for acute asthma. Ann Allergy Asthma Immunol. 2006 Feb;96(2):258-9. 14277. Cates C. Is a leukotriene receptor antagonist as effective as a long-acting beta2-agonist at reducing asthma exacerbations? Chest. 2006 Mar;129(3):826; author reply 826-7. 14278. Cates CJ, Bestall J, Adams N. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001491. Review. 14279. Coffey MJ, Ross LF. Ethics of placebos in clinical asthma trials. J Allergy Clin Immunol. 2006 Feb;117(2):470; author reply 470-1. 14280. Curtiss FR. Asthma disease management--evidence-based medicine must be dynamic. J Manag Care Pharm. 2006 Jan-Feb;12(1):80-2. 14281. Cydulka RK. Acute asthma during pregnancy. Immunol Allergy Clin North Am. 2006 Feb;26(1):103-17. Review. 14282. Davis JJ, Bailey WC. Teach a man to fish and you have fed him for a lifetime. Chest. 2006 Feb;129(2):220-1. 14283. Ekici A, Ekici M, Kara T, Keles H, Kocyigit P. Negative mood and quality of life in patients with asthma. Qual Life Res. 2006 Feb;15(1):49-56. 14284. Fan Chung K. Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol. 2006 Mar 8;533(1-3):110-7. Review. 14285. Fell DB, Dodds L, Joseph KS, Allen VM, Butler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. 2006 Feb;107 (2 Pt 1) : 277 - 84. 14286. Gelfand EW, Georgitis JW, Noonan M, Ruff ME. Once-daily ciclesonide in children: efficacy and safety in asthma. J Pediatr. 2006 Mar;148(3):377-83. 14287. Gupta RS, Bewtra M, Prosser LA, Finkelstein JA. Predictors of hospital charges for children admitted with asthma. Ambul Pediatr. 2006 Jan-Feb;6(1):15-20. 14288. Hambrook DW, Fink JN. Airbag asthma: a case report and review of the literature. Ann Allergy Asthma Immunol. 2006 Feb;96(2):369-72. Review. 14289. Jenkins A. Take a deep breath. Nurs Stand. 2006 Mar 1-7;20(25):32. 14290. Marr L. Revealing images. J Palliat Med. 2006 Feb;9(1):211-2. 14291. Mathur SK, Busse WW. Asthma: diagnosis and management. Med Clin North Am. 2006 Jan;90(1):39-60. Review. 14292. Mintz ML. Safety of long-acting beta-agonists. N Engl J Med. 2006 Mar 16;354(11):1206- 8; author reply 1206-8. 14293. Moore PA, Hersh EV. Common medications prescribed for adolescent dental patients. Dent Clin North Am. 2006 Jan;50(1):139-49, vii. 14294. Potter PC. Update on sublingual immunotherapy. Ann Allergy Asthma Immunol. 2006 Feb;96(2 Suppl 1):S22-5. Review. 14295. Prakash UB. Uncommon causes of cough: ACCP evidence-based clinical practice guide lines. Chest. 2006 Jan;129(1 Suppl):206S-219S. Review. 14296. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J Emerg Med. 2006 Mar;24(2):217-22. 14297. Sin DD, Man SF. Corticosteroids and adrenoceptor agonists: the compliments for combi nation therapy in chronic airways diseases. Eur J Pharmacol. 2006 Mar 8;533(1-3):28-35. |
|
|
October 2006
Some selected abstracts: |
|
1 |
Arcola T, Ruuska T,
Keranen J, Hyoty H, Salminen S, Isolauri E. Rectal bleeding in infancy:
clinical, allergological, and microbiological examination.Pediatrics.
2006 Apr;117(4):e760-8. |
2 |
Devadason SG. Recent advances in aerosol therapy for children with asthma. J Aerosol Med. 2006 Spring;19(1):61-6. Review. School of Paediatrics and Child Health, University of Western Australia, Princess Margaret Hospital for Children, Perth, Australia. sunalene@ichr.uwa.edu.au
Inhalational drug delivery is the primary mode of asthma therapy in
children and is the main focus of this article. Pressurized metered dose
inhalers (pMDIs) are now the method of choice in infants and children
under 5 years old, when used in combination with an appropriate valved
holding chamber or spacer. Spacers are particularly important for steroid
inhalation to maximize lung deposition and minimize unwanted oropharyngeal
deposition. Optimal inhalation technique with a pMDI-spacer in infants is
to inhale the drug by breathing tidally through the spacer. Drug delivery
to the lungs using pMDIs can vary greatly, depending on the formulation
used and the age of the child. Dry powder inhalers (DPIs) are driven by
the peak inspiratory flow of the patient and are usually not appropriate
for children under 5 or 6 years of age. Nebulizers continue to play a role
in the treatment of acute asthma where high doses of bronchodilator are
required, though multiple doses via pMDI spacer may suffice. Important
drug delivery issues specific to children include compliance, use of mask
versus mouthpiece, lower tidal volumes and inspiratory flows,
determination of appropriate dosages, and minimization of adverse local
and systemic effects. |
3 |
Heine RG. Gastroesophageal reflux disease, colic and constipation in
infants with food allergy. Curr Opin Allergy Clin Immunol. 2006
Jun;6(3):220-5. Review.
|
4 |
Hickey AJ, Lu D, Ashley ED, Stout J. Inhaled azithromycin therapy. J Aerosol Med. 2006 Spring;19(1):54-60. Division of Drug Delivery and Disposition, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599-7360, USA. ahickey@unc.edu
The
treatment of pulmonary infectious diseases with pharmaceutical aerosols is
an attractive option considering the accessibility of the lungs for
topical drug delivery. Aerosols have been targeted to the lungs for the
treatment of asthma with great success. Current therapies for other
diseases, including Pseudomonas aeruginosa, Pneumocystis jirovecii
(formerly Pneumocystis carinii), and mycobacterial infections, remain
suboptimal due to the efficacy/safety profile. This may be improved by
aerosol targeted pulmonary drug delivery. Azithromycin is a broad spectrum
antibiotic that acts by inhibiting protein synthesis. It is associated
with side effects that might be avoided by aerosol delivery to the lungs.
In the present study three concentrations of azithromycin (10, 50, and 100
mg/mL) were delivered from three nebulizers (Acorn II, Updraft, and LC
Plus) operated at 8 L/min. Particles size analyses were conducted by
inertial impaction and laser diffraction. In addition, emitted doses were
determined. A linear proportionality existed across the concentration
range between nominal dose and both fine particle dose/fraction and
emitted dose, with R2 > 0.999 in all cases. The mass median aerodynamic
diameter increased from 1.4 to 1.9 microm between 10 and 100 mg/mL of
azithromycin solution concentration for the Acorn II. The particle size
distributions were not all log-normally distributed. The median particle
size delivered from the devices was largest for the Updraft (2.8 microm)
and smallest for the Acorn II (1.9 microm) for 100 mg/mL azithromycin
solution concentrations. The efficiencies of small particle delivery
(%<4.7 microm) were as follows, LC Plus = Acorn II (85%) > UpDraft (75%).
However, the emitted dose from the LC Plus (55 mg/min) was higher than the
Acorn II (31 mg/min) to maximize lung exposure to the aerosol, small
median diameters and broad particle size distributions would be most
effective. This study demonstrates that the dose delivered to the lungs
will be maximized, under the current operating conditions by adopting the
LC Plus, and high (100 mg/mL) azithromycin concentrations. |
5 |
Shiber JR, Santana J. Dyspnea. Med Clin North Am. 2006 May;90(3):453-79.
Review. |
6 |
Sun
HL, Kao YH, Chou MC, Lu TH, Lue KH. Differences in the prescription
patterns of anti-asthmatic medications for children by pediatricians,
family physicians and physicians of other specialties. J Formos Med Assoc.
2006 Apr;105(4):277-83.
|
7 |
Watanasomsiri A, Phipatanakul W. Comparison of nebulized ipratropium
bromide with salbutamol vs salbutamol alone in acute asthma exacerbation
in children. Ann Allergy Asthma Immunol. 2006 May;96(5):701-6.
|
8 |
Zwerneman K. End-tidal carbon dioxide monitoring: a VITAL sign worth
watching. Crit Care Nurs Clin North Am. 2006 Jun;18(2):217-25, xi. Review. |
Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics: 14651. Al-Shawwa B, Al-Huniti N, Titus G, Abu-Hasan M. Hypercholesterolemia is a potential risk factor for asthma. J Asthma. 2006 Apr;43(3):231-3. 14652. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006 May;117(5):e817-20. 14653. Christopher KL. Understanding vocal cord dysfunction: a step in the right direction with a long road ahead.Chest. 2006 Apr;129(4):842-3. 14654. Cockcroft DW, Davis BE. Deep inhalation bronchoprotection in asthma: correlation with airway responsiveness. J Allergy Clin Immunol. 2006 Apr;117(4):951-2. 14655. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006 May;12 Suppl 3:12-24. Review. 14656. Delfino RJ. Who are the children with asthma most susceptible to air pollution? Am J Respir Crit Care Med. 2006 May 15;173(10):1054-5. 14657. Dinakar C, Simon S. The link between the Hippocratic Oath and evidence-based medicine. Ann Allergy Asthma Immunol. 2006 Apr;96(4):511-3. 14658. Eschenauer GA, Regal RE, DePestel DD. Antibiotic allergy.N Engl J Med. 2006 May 25;354(21):2293-4. 14659. Flaherman V, Rutherford GW. A meta-analysis of the effect of high weight on asthma.Arch Dis Child. 2006 Apr;91(4):334-9. Review. 14660. Heraghty JL, Henderson AJ. Highlights in asthma 2005. Arch Dis Child.2006 May;91(5):422-5. Review. 14661. Kanter RK, Moran JR. Recent trends in pediatric hospitalization in New York state. J Pediatr. 2006 May;148(5):637-641. 14662. Kraft M, Hamid Q. Mycoplasma in severe asthma. J Allergy Clin Immunol. 2006 May;117(5):1197-8. 14663. Kugelman A, Shaoul R, Goldsher M, Srugo I. Persistent cough and failure to thrive: a presentation of foreign body aspiration in a child with asthma. Pediatrics. 2006 May;117(5):e1057-60. 14664. Kuzucu A. Parasitic diseases of the respiratory tract. Curr Opin Pulm Med. 2006 May;12(3):212-21. Review. 14665. Kwon NH, Oh MJ, Min TH, Lee BJ, Choi DC. Causes and clinical features of subacute cough. Chest. 2006 May;129(5):1142-7. 14666. Linday LA. Nutritional supplements and pediatric upper respiratory tract illnesses. J Allergy Clin Immunol. 2006 Apr;117(4):953-4; author reply 954. 14667. Niggemann B, Heine RG. Who should manage infants and young children with food induced symptoms? Arch Dis Child. 2006 May;91(5):379-82. 14668. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med. 2006 Jun;47(6):559-63. 14669. Raherison C, Abouelfath A, Le Gros V, Taytard A, Molimard M. Underdiagnosis of nocturnal symptoms in asthma in general practice. J Asthma. 2006 Apr;43(3):199-202. 14670. Rowe BH, Camargo CA Jr. Emergency department treatment of severe acute asthma. Ann Emerg Med. 2006 Jun;47(6):564-6. 14671. Siddiqui AM, Bardapurkar JS, Patil VP. Oxidant and antioxidants in bronchial asthma. Indian Med Gazette 2005, 139(5), 174-7. 14672. Weinberger M. Exercise induced dyspnoea: if not asthma, then what? Arch Dis Child. 2006 Jun;91(6):543-4. 14673. Yasmeen S, Romano PS, Schembri ME, Keyzer JM, Gilbert WM. Accuracy of obstetric diagnoses and procedures in hospital discharge data. Am J Obstet Gynecol. 2006 Apr;194(4):992-1001. Therapy: 14651. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006 May 11;354(19):1998-2005. 14652. Brightling CE. Clinical applications of induced sputum. Chest. 2006 May;129(5):1344-8. Review. 14653. Burns SM. Ventilating patients with acute severe asthma: what do we really know? AACN Adv Crit Care. 2006 Apr-Jun;17(2):186-93. Review. 14654. Cox G, Miller JD, McWilliams A, Fitzgerald JM, Lam S. Bronchial thermoplasty for asthma. Am J Respir Crit Care Med. 2006 May 1;173(9):965-9. 14655. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006 May;117(5):1021-35. 14656. Donohue JF, Fromer L. Long-acting beta-agonists role in asthma management. J Fam Pract. 2006 Apr;Suppl:1-6. Review. 14657. Glassroth J. The role of long-acting beta-agonists in the management of asthma: analysis, meta-analysis, and more analysis. Ann Intern Med. 2006 Jun 20;144(12):936-7. 14658. Harmanci K, Bakirtas A, Turktas I, Degim T. Oral montelukast treatment of preschool-aged children with acute asthma. Ann Allergy Asthma Immunol. 2006 May;96(5):731-5. 14659. Hermansen MN, Nielsen KG, Buchvald F, Jespersen JJ, Bengtsson T, Bisgaard H. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol inchildren with persistent asthma. Chest. 2006 May;129(5):1203-9. 14660. Heymann WR. Intramuscular triamcinolone. J Am Acad Dermatol. 2006 May;54(5):866-7. 14661. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB; TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006 Apr 13;354(15):1589-600. 14662. Karagiannidis C, Hense G, Rueckert B, Mantel PY, Ichters B, Blaser K, Menz G, Schmidt-Weber CB. High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol. 2006 Apr;63(4):304-10. 14663. Koopmans JG, Lutter R, Jansen HM, van der Zee JS. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Thorax. 2006 Apr;61(4):306-12. 14664. Lipworth B. Phosphodiesterase type 4 inhibitors for asthma: a real breakthrough or just expensive theophylline? Ann Allergy Asthma Immunol. 2006 May;96(5):640-2. 14665. Little FF. Treating acute asthma with antibiotics--not quite yet. N Engl J Med. 2006 Apr 13;354(15):1632-4. 14666. Palmer K, Burks W. Current developments in peanut allergy. Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):202-6. Review. 14667. Stumpf JL, Shehab N, Patel AC. Safety of Angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother. 2006 Apr;40(4):699-703 14668. Xue CC, Li CG, Hugel HM, Story DF. Does acupuncture or Chinese herbal medicine have a role in the treatment of allergic rhinitis? Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):175-9. Review. 14669. Yu JW, Pekeles G, Legault L, McCusker CT. Milk allergy and vitamin D deficiency rickets: a common disorder associated with an uncommon disease. Ann Allergy Asthma Immunol. 2006 Apr;96(4):615-9. |